CLINICAL TRIAL OF HEMATOPOIETIC STEM CELL GENE THERAPY FOR WISKOTT-ALDRICH-SYNDROME
- 8 Anni 2010/2018
- 4.079.127€ Totale Fondi
Descrizione non disponibile
Pubblicazioni Scientifiche
- 2011 Blood
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression
- 2014 CURRENT GENE THERAPY
Gene Therapy for Wiskott-Aldrich Syndrome
- 2016 JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
A novel genomic inversion in Wiskott-Aldrich–associated autoinflammation